Nav button
About Us
Our Company
Leadership
Founders
Scientific Advisory Board
Contact Us
Science
SLT
x
PLatform
Publications
Pipeline
Patients & Caregivers
Overview
Diabetes
Lysosomal Diseases
Press Releases
Inside Sigilon
Our Culture
Job Opportunities
Media Coverage
Back to Media Coverage
Tunable Cell Therapies
Sigilon’s allogeneic cell therapy implants offer long-term but flexible dosing.